TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Clinical trial NCT04109924 · COMPLETED

Trial details

NCT number: NCT04109924
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Colorectal Carcinoma Metastatic Colon Adenocarcinoma Metastatic Rectal Adenocarcinoma Recurrent Colon Adenocarcinoma Recurrent Colorectal Adenocarcinoma Recurrent Rectal Adenocarcinoma Stage III Colon Cancer AJCC v8 Stage III Colorectal Cancer AJCC v8 Stage III Rectal Cancer AJCC v8 Stage IIIA Colon Cancer AJCC v8 Stage IIIA Colorectal Cancer AJCC v8 Stage IIIB Colorectal Cancer AJCC v8

Start date: 2019-12-27
Primary completion: 2024-09-05
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.